Clinical Trials Logo

Filter by:
NCT ID: NCT04672174 Enrolling by invitation - Clinical trials for Hearing Loss, Sensorineural

Cognitive Screening Of Patients With Hearing Loss

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Hearing loss and cognitive impairment both appear in elderly patients. The goal was to use a modified screening method added to already established cognitive tests to obtain a standardized test for detection of cognitive impairment in patients with hearing loss. The aim of this study is to collect data with neuropsychological tests using questionnaires and to determine cognitive impairment in patients with hearing loss. The collected data will be evaluated using SPSS 23. The corrected item-total correlation and item difficulty of the item DemTectEar will be assessed by item analysis / Cronbachs' Alpha. For further evaluation and comparisons two-sided t-tests with a level of significance 0.05 or Mann-Whitney-U-tests will be performed.

NCT ID: NCT04671433 Active, not recruiting - Clinical trials for X-Linked Retinitis Pigmentosa

Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Start date: December 4, 2020
Phase: Phase 3
Study type: Interventional

A clinical trial of AAV5-RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

NCT ID: NCT04671043 Completed - Placebo Clinical Trials

Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes

DE-CAF
Start date: February 4, 2022
Phase: N/A
Study type: Interventional

This project will aim to investigate the clinical efficacy and metabolic effects of a pre-exercise dose of caffeine with a low (10g) dose of carbohydrate (CAF+lowCHO) without modification of insulin degludec on exercise metabolism in people with T1D.

NCT ID: NCT04670601 Completed - Healthy Clinical Trials

Bioequivalence of Flurbiprofen Lozenge vs Strepfen

Start date: June 19, 2018
Phase: Phase 1
Study type: Interventional

The present study has been designed to compare flurbiprofen pharmacokinetic profile after administration of flurbiprofen 8.75 mg lozenges, marketed by ACRAF, S.p.A., Italy (test product), and the marketed Strepfen 8.75 mg honey and lemon lozenges reference product. (Reckitt Benckiser Portugal SA).

NCT ID: NCT04670523 Recruiting - Clinical trials for Lung Pathologies of Unclear Etiology

Early Postoperative Day 0 Chest Tube Removal After Thoracoscopic Minor Surgeries

CTremoval
Start date: January 6, 2023
Phase: N/A
Study type: Interventional

The safe conditions for early chest tube removal have been progressively questioned and redefined around reliable digital air flow criteria and extension of liquid threshold accepted. Nevertheless, in current practice, the chest tube remains in restricting early mobilization and optimal compliance with ERAS programme, during the first crucial 24 h after surgery. Thus, to go further, the investigators decide to assess in this study the safety of POD 0 chest tube removal after minor thoracic operations in patients in health condition tolerating operation and anesthesia.

NCT ID: NCT04669717 Recruiting - Pharmacokinetics Clinical Trials

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies

AMA
Start date: September 1, 2021
Phase: Phase 4
Study type: Interventional

Periodontitits is a bacteria induced inflammatory disease that destroys the supporting tissues of the tooth and leads to tooth loss. Treatment consists mainly of the mechanical cleaning of the tooth surfaces in order to remove the bacterial deposits (plaque and calculus). This procedure can reduce the level of pathogenic bacteria but it can not eradicate them. In severe cases, for the complete resolution of the disease, the elimantion of certain species of bacteria is needed. In order to achieve that, the combination of different regimens of antibiotics adjunctive to the mechanical treatment has been proposed. However, dosage and duration of antimicrobial therapy should be optimal and not excessive as issues may arise related to increased antimicrobial resistance in the population and the individual due to habitual prescription of wide-spectrum antibiotic regimens, horizontal gene transfer and genetic mutation. In the present study, in an effort to optimize the dosage and duration of the antimicrobial regimen, we will determine the pharmacokinetics (PK) and pharmacodynamic (PD) properties of the MET-AMO combination and of AZI in Gingival Crevicular Fluid (GCF), saliva and serum in severe periodontitis patients during and after either a 3-day or a 7-day course of treatment.

NCT ID: NCT04669626 Completed - Wound Heal Clinical Trials

The Ability of Octenilin® to Reduce Odour of Malodorous Wound

Odour
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Malodours are a common complication of chronic wounds. They are the result of the proliferation of aerobic and anaerobic micro-organisms on the wound surface, where they metabolize healthy tissue which leads to the production of sloughy and even necrotic tissue. Wound odour has a big impact on the quality of life of patients. Currently the standard of care for the management of malodourous wounds are systemic antibiotics, absorbent wound dressings with or without activated carbon and, topical antimicrobials. The application of topical antimicrobials such as antiseptics against wound odour is part of the standard care. One suggested antiseptic in a recent published standard is Octenilin®. There is ample anecdotal evidence about the efficacy of Octenilin® in reducing wound odour. Therefore, we propose here to document this ability by evaluating the odour of wounds washed with Octenilin® versus standard care (NaCl 0.9% solution).

NCT ID: NCT04668261 Recruiting - Clinical trials for Brain Blood Flow Impairment

Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients

Start date: January 1, 2021
Phase:
Study type: Observational

Primary study objective: • Longitudinal observation of brain blood flow changes in neurosurgical patients with or without a neurosurgical intervention as compared to a healthy cohort. Secondary study objectives: - Longitudinal observation of hemodynamic patterns versus structural brain tissue changes in neurosurgical patients. - Changes in blood flow patterns and structural brain tissue after neurosurgical interventions as compared to a healthy cohort. - Determining hemodynamic imaging patterns that can be tested as novel imaging markers.

NCT ID: NCT04666857 Completed - Clinical trials for Congenital Heart Disease in Children

Family Centred Early Intervention of Infants With Congenital Heart Disease

Start date: May 31, 2021
Phase: N/A
Study type: Interventional

In this study the investigators aim to test the feasibility for therapists and acceptability to parents of an early motor intervention for infants with congenital heart disease (CHD) after open heart surgery. This intervention will be compared to the standard care of treatment that is recommended for infants with congenital heart disease at the University Children Hospital Zurich.

NCT ID: NCT04666623 Withdrawn - Cancer Pain Clinical Trials

Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory Pain

IMPORTANCE
Start date: November 25, 2020
Phase: Phase 2
Study type: Interventional

This study is to assess the efficacy and safety of a four-week treatment with intranasal esketamine (56 mg) twice a week combined with opioid analgesic and adjuvant standard therapy in the management of adult patients with severe and opioid refractory chronic cancer pain.